Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026)

Xencor (XNCR) posted quarterly Change in Acquisitions & Divestments of $100.0 million for Q1 2026, down 15.98% year-over-year from $119.0 million in Q1 2025, and up 14.9% quarter-over-quarter from $87.0 million in Q4 2025.

Analysis

Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026) Analysis & Trends

Xencor (XNCR) has reported Change in Acquisitions & Divestments for 12 consecutive years, with $100.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 15.98% year-over-year to $100.0 million; the TTM figure through Mar 2026 stood at $386.1 million (down 44.77% YoY), while the FY2025 annual figure was $405.1 million, down 31.35% from the prior year.
  • Change in Acquisitions & Divestments advanced to $100.0 million in Q1 2026 per XNCR's latest filing, from $87.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $471.7 million in Q3 2024 and bottomed at -$339.6 million in Q3 2023.
  • Historically, Change in Acquisitions & Divestments has averaged $73.0 million across 5 years, with a median of $87.0 million in 2025.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 1093.55% in 2025 and fell as far as 1741.72% in 2025.
  • Xencor's Change in Acquisitions & Divestments stood at -$205.3 million in 2022, then plunged by 65.41% to -$339.6 million in 2023, then jumped by 133.61% to $114.1 million in 2024, then slipped by 23.78% to $87.0 million in 2025, then gained by 14.9% to $100.0 million in 2026.
  • Business Quant data shows XNCR's Change in Acquisitions & Divestments at $100.0 million in Q1 2026, $87.0 million in Q4 2025, and $304.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.65 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.00 Mn
Mar 31, 2026 99.97 Mn
Dec 31, 2025 87.00 Mn
Sep 30, 2025 98.71 Mn
Jun 30, 2025 100.40 Mn
Mar 31, 2025 118.99 Mn
Dec 31, 2024 114.14 Mn
Sep 30, 2024 117.98 Mn
Jun 30, 2024 197.99 Mn
Mar 31, 2024 159.94 Mn
Dec 31, 2023 137.00 Mn
Sep 30, 2023 216.51 Mn
Jun 30, 2023 185.02 Mn
Mar 31, 2023 154.56 Mn
Dec 31, 2022 101.32 Mn
Sep 30, 2022 128.90 Mn
Jun 30, 2022 56.39 Mn
Mar 31, 2022 20.00 Mn
Dec 31, 2021 141.27 Mn
Sep 30, 2021 122.13 Mn